Shou I - Search Results

1

Pharmacokinetics of calcitriol and maxacalcitol administered into peritoneal dialysate bags in peritoneal dialysis patients.

Hamada C, Hayashi K, Shou I, Inaba M, Ro Y, Io H, Maeda K, Fukui M, Tomino Y. Hamada C, et al. Among authors: shou i. Perit Dial Int. 2005 Nov-Dec;25(6):570-5. Perit Dial Int. 2005. PMID: 16411524

2

Evaluation of parathyroid hyperplasia by ultrasonographic examination in patients with end-stage renal failure before and at initiation of dialysis.

Hamada C, Fukui M, Sakamoto T, Koizumi M, Ishiguro C, Osada S, Shou I, Hayashi K, Tomino Y. Hamada C, et al. Among authors: shou i. Nephrology (Carlton). 2003 Jun;8(3):116-20. doi: 10.1046/j.1440-1797.2003.00145.x. Nephrology (Carlton). 2003. PMID: 15012726

3

Parathyroid hormone gene polymorphism and secondary hyperparathyroidism in hemodialysis patients.

Gohda T, Shou I, Fukui M, Funabiki K, Horikoshi S, Shirato I, Tomino Y. Gohda T, et al. Among authors: shou i. Am J Kidney Dis. 2002 Jun;39(6):1255-60. doi: 10.1053/ajkd.2002.33399. Am J Kidney Dis. 2002. PMID: 12046039

4

Usefulness of a body composition analyzer, InBody 2.0, in chronic hemodialysis patients.

Okamoto M, Fukui M, Kurusu A, Shou I, Maeda K, Hamada C, Tomino Y. Okamoto M, et al. Among authors: shou i. Kaohsiung J Med Sci. 2006 May;22(5):207-10. doi: 10.1016/S1607-551X(09)70237-2. Kaohsiung J Med Sci. 2006. PMID: 16793554 Free article.

5

Long-term effects of the oral adsorbent, AST-120, in patients with chronic renal failure.

Maeda K, Hamada C, Hayashi T, Shou I, Wakabayashi M, Fukui M, Horikoshi S, Tomino Y. Maeda K, et al. Among authors: shou i. J Int Med Res. 2009 Jan-Feb;37(1):205-13. doi: 10.1177/147323000903700125. J Int Med Res. 2009. PMID: 19215692 Free article. Clinical Trial.

6

[Goodpasture syndrome].

Shou I, Tomino Y. Shou I, et al. Nihon Rinsho. 2002 Jan;60 Suppl 1:112-9. Nihon Rinsho. 2002. PMID: 11838103 Review. Japanese. No abstract available.

7

Serum cystatin C is a more sensitive marker of glomerular function than serum creatinine.

Shimizu-Tokiwa A, Kobata M, Io H, Kobayashi N, Shou I, Funabiki K, Fukui M, Horikoshi S, Shirato I, Saito K, Tomino Y. Shimizu-Tokiwa A, et al. Among authors: shou i. Nephron. 2002 Sep;92(1):224-6. doi: 10.1159/000064453. Nephron. 2002. PMID: 12187109

8

Effects of the PGI2 analog beraprost sodium on glomerular prostanoid synthesis in rats with streptozotocin-induced diabetes.

Wang LN, Tang Z, Shou I, Fukui M, Tomino Y. Wang LN, et al. Among authors: shou i. Nephron. 1996;73(4):637-43. doi: 10.1159/000189152. Nephron. 1996. PMID: 8856263

9

Efficacy of ACE inhibitor (captopril) on glomerular antioxidant enzyme activity and hypertension in diabetic hypertensive rats.

Shou I, Fukui M, Tomino Y. Shou I, et al. Contrib Nephrol. 2001;(134):74-8. doi: 10.1159/000060135. Contrib Nephrol. 2001. PMID: 11665291 Review. No abstract available.

10

Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia--changes in serum potassium levels with or without a RAAS inhibitor.

Tomino Y, Yamazaki T, Shou I, Tsuge T, Satake K, Takeda Y, Ohtani A, Nishitani T, Kurusu A, Hamada C, Horikoshi S, Maeda K, Tanaka Y, Fukuda H, Wakabayashi M, Seto T. Tomino Y, et al. Among authors: shou i. Clin Nephrol. 2007 Dec;68(6):379-85. doi: 10.5414/cnp68379. Clin Nephrol. 2007. PMID: 18184520

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters